SILDENAFIL FOR EARLY PULMONARY VASCULAR DISEASE IN SCLERODERMA

$2,337,597FY2020Defense Health AgencyDOD

The Johns Hopkins University

Investigators

View source on USAspending →

SILDENAFIL FOR EARLY PULMONARY VASCULAR DISEASE IN SCLERODERMA · GrantIndex